0111 HHS notice
BioCentury & Getty Images


HHS imposes new review timeline report policy on FDA

Jan 12, 2021 | 1:19 AM GMT

HHS Monday announced that it will require FDA to collect and report data about the length of new drug reviews using metrics that are different, and far more stringent, than those the agency has traditionally used.

In addition, HHS stated that some waivers of premarket notification requirements for medical devices

Read the full 694 word article

How to gain access

Continue reading with a
two-week free trial.